Findings

What do systematic reviews say?

1 questions · 1 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 100%High 0 · 0%

Adverse events incidence · patients with stable angina pectoris

Ranolazine (add‐on therapy) probably leads to higher adverse events incidence compared with placebo (moderate certainty).

1 finding from 1 review

Ranolazine for stable angina pectoris 2017 · Cochrane Headline outcomes only
RR 1.22 [1.06, 1.4]
3 studies · 2123 participants
Moderate